During the past decade, Consorci Sanitari del Maresme conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Consorci Sanitari del Maresme" #1 sponsor was "Consorci Sanitari del Maresme" with 5 trials, followed by "Hospital de Mataró" with 4 trials sponsored, "AB Biotics, SA" with 1 trials sponsored, "Fundacion Iberoamericana Itaca" with 1 trials sponsored and "Hospital Parc Taulí, Sabadell" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Consorci Sanitari del Maresme" #1 collaborator was "Centro Investigación Biomédica en Red de Enfermedades Hepáticas Digestivas" with 1 trials as a collaborator, "Instituto de Salud Carlos III" with 1 trials as a collaborator, "Laboratorios del Dr. Esteve, S.A." with 1 trials as a collaborator, "Nutricia Research" with 1 trials as a collaborator and "PRODUCTOS SANITARIOS ECA-RVB SLI" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Consorci Sanitari del Maresme" are "Oropharyngeal Dysphagia" (4 trials), "Elderly" (2 trials), "Swallowing Disorder" (2 trials), "Borderline Personality Disorder" (1 trials) and "Bowel Cancer" (1 trials). Many other conditions were trialed in "Consorci Sanitari del Maresme" in a lesser frequency.

Most popular intervention types in "Consorci Sanitari del Maresme" are "Other" (7 trials), "Drug" (5 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "1-day low residue diet" (1 trials), "Bisacodyl 5 MG" (1 trials), "Calcium Dobesilate" (1 trials), "Capsaicin 10microM (TRPV1 natural agonist)" (1 trials) and "Capsaicin 10microM + Citric acid 457,5microM (pH=3,5) (TRPV1 & ASIC3 natural agonists)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Consorci Sanitari del Maresme" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Consorci Sanitari del Maresme". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Consorci Sanitari del Maresme, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Consorci Sanitari del Maresme, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".

Consorci Sanitari del Maresme has several departments that took part in Clinical trials: "Hospital General de Mataro; Servicio de Oncologia" - 2 trials